Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2019 Published Date: Jun 2015 Global Restless Legs Syndrome Market

Report Description RLS is a neurological disease; it is also known as Willis-Ekbom disease. People with RLS experience an overwhelming desire to move their legs. It leads to an unpleasant pain in the limbs, leading to a disturbance in sleep pattern of patients. The condition aggravates at night or when the person is at rest. It occurs in both genders, but higher prevalence is seen in women than men. It affects people of all ages but mostly affecting the middle-aged and elderly people. Its common symptoms are uncomfortable itching pain in the legs, leading to a disruption in the sleep pattern and ultimately affecting the quality of life of individuals. The precise cause of RLS is not known but with the extensive investigations done in the field, it is believed to be due to predisposing genetic factors or due to low levels of iron in the brain or due to the disturbances in the dopaminergic balance. Till date, there is no specific cure for the disorder. The drugs present in the market help in the symptomatic treatment of the disorder and in relieving the uneasiness caused due to this disorder. Get Complete Report At: syndrome markethttp:// syndrome market The global RLS market to grow at a CAGR of 11.46% over the period

Report Description Covered in this report This report covers the present scenario and the growth prospects of the global RLS market for the period To calculate the market size, the report considers the revenue generated from the sales of various generic, off-label, and branded therapies used for the treatment of RLS. The Global RLS Market , has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key regions Americas APAC EMEA Enquire About This report:

Report Description Key vendors Boehringer Ingelheim GlaxoSmithKline UCB XenoPort Other prominent vendors Alexza Pharmaceuticals Astellas Pharma Axxonis Pharma Bayer Healthcare Impax Pharmaceuticals Luitpold Pharmaceuticals Merz Pharmaceuticals Mundipharma Newron Pharmaceuticals Serina Therapeutics Teva Neuroscience

Report Description Market driver High unmet medical needs For a full, detailed list, view our report Market challenge Unknown disease etiology For a full, detailed list, view our report Market trend Expected entry of drugs with multiple mechanisms and novel technologies For a full, detailed list, view our report Key questions answered in this report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?

Table Of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Product Profiles 06. Introduction 07. Disease Overview 08. Pipeline Analysis 09. Commercial Opportunities 10. Key Brand Analysis 11. Market Landscape 12. Market Segmentation by Class of Drugs 13. Geographical Segmentation 14. Buying Criteria 15. Market Growth Drivers 16. Drivers and their Impact 17. Market Challenges 18. Impact of Drivers and Challenges Get Complete TOC At: syndrome markethttp:// syndrome market

FOR MORE DETAILS Visit us at : legs-syndrome market Stay With Us: TELEPHONE: +1 (855) NE Win Sivers Drive, #205, Portland, OR United States